- Home
- ASTI vs KTTA Comparison
ASTI vs KTTA Comparison
Compare ASTI & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- KTTA
- Stock Information
- Founded
- ASTI 2005
- KTTA 2020
- Country
- ASTI United States
- KTTA United States
- Employees
- ASTI N/A
- KTTA N/A
- Industry
- ASTI Semiconductors
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- ASTI Technology
- KTTA Health Care
- Exchange
- ASTI Nasdaq
- KTTA Nasdaq
- Market Cap
- ASTI 6.7M
- KTTA 5.7M
- IPO Year
- ASTI N/A
- KTTA 2021
- Fundamental
- Price
- ASTI $1.67
- KTTA $0.73
- Analyst Decision
- ASTI
- KTTA
- Analyst Count
- ASTI 0
- KTTA 0
- Target Price
- ASTI N/A
- KTTA N/A
- AVG Volume (30 Days)
- ASTI 582.2K
- KTTA 105.8K
- Earning Date
- ASTI 11-10-2025
- KTTA 11-14-2025
- Dividend Yield
- ASTI N/A
- KTTA N/A
- EPS Growth
- ASTI N/A
- KTTA N/A
- EPS
- ASTI N/A
- KTTA N/A
- Revenue
- ASTI $61,134.00
- KTTA N/A
- Revenue This Year
- ASTI N/A
- KTTA N/A
- Revenue Next Year
- ASTI N/A
- KTTA N/A
- P/E Ratio
- ASTI N/A
- KTTA N/A
- Revenue Growth
- ASTI 36.85
- KTTA N/A
- 52 Week Low
- ASTI $1.10
- KTTA $0.65
- 52 Week High
- ASTI $4.41
- KTTA $3.85
- Technical
- Relative Strength Index (RSI)
- ASTI 35.66
- KTTA 44.79
- Support Level
- ASTI $1.43
- KTTA $0.65
- Resistance Level
- ASTI $1.78
- KTTA $0.75
- Average True Range (ATR)
- ASTI 0.17
- KTTA 0.05
- MACD
- ASTI -0.06
- KTTA -0.01
- Stochastic Oscillator
- ASTI 25.28
- KTTA 31.40
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).